Adagio Medical Holdings (ADGM) Equity Average (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Equity Average data on file, last reported at $9.1 million in Q1 2026.

• Equity Average for Q1 2026 came in at $9.1 million, down 43.9% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.1 million (down 43.9% YoY), and the FY2025 annual result was $16.2 million, up 128.82% from the prior year.
• Equity Average climbed to $9.1 million in Q1 2026 per ADGM's latest filing, from $5.5 million in the prior quarter.
• Over five years, Equity Average peaked at $48.2 million in Q4 2024 and troughed at -$139.9 million in Q2 2024.
• A 4-year average of -$34.2 million and a median of $4.6 million in 2025 frame the typical range for Equity Average.
• The sharpest annual moves came in 2024 and 2025: Equity Average surged 137.75% in 2024, then plunged 88.5% in 2025.
• A 4-year view of Equity Average shows it stood at -$127.8 million in 2023, then surged by 137.75% to $48.2 million in 2024, then sank by 88.5% to $5.5 million in 2025, then surged by 63.45% to $9.1 million in 2026.
• Business Quant data shows ADGM's Equity Average at $9.1 million in Q1 2026, $5.5 million in Q4 2025, and $3.7 million in Q3 2025.